Document type

Article

Version

Accepted version

Publication date

Publication license

cc-by-nc-nd (c) SenoNetwork;Churchill Livingstone; European Society of Breast Cancer Specialists (EUSOMA), 2020
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/170415

Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer

Journal Title

Director/Tutor

Additional contribution

Journal ISSN

Volume Title

Abstract

Metastatic breast cancer (MBC) diagnosis in young women negatively impacts on quality of life (QoL) and daily activities, disrupting their life project and forcing them to face new psychosocial challenges. The recently published results on the improvement of the overall survival of pre- or perimenopausal women with hormone-receptor-positive, HER2-negative MBC treated with CDK4/6 inhibitors plus endocrine therapy, while preserving, and in some items improving their QoL, will change the landscape of the management of this patient population. Their extended survival and potential improvement in QoL will, therefore, modify their specific needs in terms of psychosocial support. The complexity of the care of young women with MBC is described herein, based on an extensive literature review. Further research about the specific psychosocial requirements of these women and a new multidisciplinary holistic approach is paramount to properly address their concerns and preferences. The communication with and support of their partners, parents and children is an important factor affecting the QoL of these patients. Altogether, a multidisciplinary care, open communication and personalized support is required to address the psychosocial implications of the new prognostic expectations on these patients with the incorporation of new targeted therapies.

Citation

Citation

MARGELÍ VILA, Mireia, et al. Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer. The Breast. 2020. Vol. 53, num. 44-50. ISSN 0960-9776. [consulted: 6 of October of 2026]. Available at: https://hdl.handle.net/2445/170415

Export metadata

JSON - METS

Share record